<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Monocytes obtained from patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) were examined for differentiation markers (expression of CD14 and antigens reacting with monoclonal antibodies 25F9 and G16/1) and for expression of selected <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules </plain></SENT>
<SENT sid="1" pm="."><plain>There was significantly raised expression of the CD14 molecule, and increased staining with 25F9 and G16/1 antibodies in monocytes obtained from patients with BD </plain></SENT>
<SENT sid="2" pm="."><plain>A monocyte activation marker, soluble CD14, was also found to be raised in patients' serum compared with <z:mpath ids='MPATH_458'>normal</z:mpath> serum (8.1 +/- 9.2 vs 1.4 +/- 0.7 micrograms/ml) </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, BD patients' monocyte culture supernatants caused significantly increased <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of <z:mpath ids='MPATH_458'>normal</z:mpath> neutrophils to endothelial cell monolayers in vitro </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these findings show that BD patients' monocytes are active in vivo and produce a number of pro-inflammatory cytokines which may play a role in the <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> found in these patients </plain></SENT>
</text></document>